Toxicities | N group | CRT group | P |
---|---|---|---|
Leukopenia | < 0.001 | ||
G0 | 25 (78.1%) | 16 (29.1%) | |
G1 | 7 (21.9%) | 17 (30.9%) | |
G2 | 0 (0.0%) | 14 (25.5%) | |
G3 | 0 (0.0%) | 6 (10.9%) | |
G4 | 0 (0.0%) | 2 (3.6%) | |
Neutropenia | < 0.001 | ||
G0 | 30 (93.7%) | 22 (40.0%) | |
G1 | 2 (6.3%) | 14 (25.5%) | |
G2 | 0 (0.0%) | 12 (21.8%) | |
G3 | 0 (0.0%) | 5 (9.1%) | |
G4 | 0 (0.0%) | 2 (3.6%) | |
Anemia | 0.085 | ||
G0 | 29 (90.7%) | 37 (67.3%) | |
G1 | 1 (3.1%) | 10 (18.2%) | |
G2 | 1 (3.1%) | 6 (10.9%) | |
G3 | 1 (3.1%) | 2 (3.6%) | |
Thrombocytopenia | 0.082 | ||
G0 | 31 (96.9%) | 42 (76.4%) | |
G1 | 1 (3.1%) | 5 (9.1%) | |
G2 | 0 (0.0%) | 6 (10.9%) | |
G3 | 0 (0.0%) | 2 (3.6%) | |
Hepatoxicity | 0.009 | ||
G0 | 28 (87.5%) | 30 (54.6%) | |
G1 | 4 (12.5%) | 13 (23.6%) | |
G2 | 0 (0.0%) | 11 (20.0%) | |
G3 | 0 (0.0%) | 1 (1.8%) | |
Weight Loss | 0.047 | ||
G0 | 29 (90.6%) | 40 (72.7%) | |
G1 | 3 (9.4%) | 15 (27.3%) | |
Salivary glands injury | 0.538 | ||
G0 | 3 (9.4%) | 2 (3.6%) | |
G1 | 27 (84.3%) | 49 (89.1%) | |
G2 | 2 (6.3%) | 4 (7.3%) | |
Dermatitis | 0.005 | ||
G0 | 12 (37.5%) | 4 (7.3%) | |
G1 | 17 (53.1%) | 45 (81.8%) | |
G2 | 3 (9.4%) | 5 (9.1%) | |
G3 | 0 (0.0%) | 1 (1.8%) | |
Nausea | < 0.001 | ||
G0 | 28 (87.5%) | 21 (38.2%) | |
G1 | 3 (9.4%) | 29 (52.7%) | |
G2 | 1 (3.1%) | 5 (9.1%) | |
Vomiting | 0.612 | ||
G0 | 28 (87.5%) | 45 (81.8%) | |
G1 | 3 (9.4%) | 4 (7.3%) | |
G2 | 1 (3.1%) | 5 (9.1%) | |
G3 | 0 (0.0%) | 1 (1.8%) | |
Mucositis oral | 0.002 | ||
G0 | 12 (37.5%) | 3 (5.5%) | |
G1 | 16 (50.0%) | 40 (72.7%) | |
G2 | 3 (9.4%) | 10 (18.2%) | |
G3 | 1 (3.1%) | 2 (3.6%) |